KIMBERLY ROBINSON: Open Payments
NPI 1003040320 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 39 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $431 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $432 |
| Corium, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $27 |
| Biogen, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, Azstarys, LYBALVI, ZURZUVAE, COBENFY, REXULTI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
